等待开盘 04-02 09:30:00 美东时间
+0.050
+8.20%
今日重点评级关注:巴克莱:维持C4 Therapeutics"超配"评级,目标价从5美元升至7美元;富国银行:维持Agilon Health"超配"评级,目标价从1美元升至1.5美元
03-02 14:08
Canaccord Genuity analyst George Gianarikas maintains Arbe Robotics (NASDAQ:ARBE) with a Buy and lowers the price target from $1.75 to $1.25.
02-28 02:32
Arbe Robotics (NASDAQ:ARBE) sees FY2026 sales of $4.000 million-$6.000 million vs $8.291 million analyst estimate.
02-26 20:04
The earnings results for Arbe Robotics (NASDAQ:ARBE) for Q4 were made public on...
02-26 20:04
Arbe Robotics (NASDAQ:ARBE) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.09) by 11.11 percent. This is a 27.27 percent increase over losses of $(0.11) per share from the
02-26 20:04
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
Advanced radar-based safety technology gains traction across automotive and smart-city markets NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Market News Updates News Commentary - The Vulnerable Roa...
02-06 21:50
Arbe Robotics (ARBE) has priced an underwritten offering of 11.5M ordinary shares at a purchase price of $1.40 per share for gross proceeds of ~$16.1M. The underwriters have a 30-day option to purchas...
01-26 21:34
Arbe estimates the gross proceeds from this offering to be approximately $16.1 million before deducting underwriting discounts and commissions and other offering expenses. Arbe expects to grant the underwriters a
01-26 21:03
Arbe Robotics Ltd. has priced an underwritten offering of 11.5 million ordinary shares at $1.40 per share, with gross proceeds estimated at $16.1 million. The company may grant underwriters an option to purchase up to an additional 1.725 million shares. Proceeds will be used for working capital and general corporate purposes. The offering is expected to close on January 27, 2025. Canaccord Genuity is the sole bookrunner, with Roth Capital Partner...
01-26 13:00